Low dose oral methotrexate treatment of multiple sclerosis: a pilot study
- PMID: 8229034
- PMCID: PMC489824
- DOI: 10.1136/jnnp.56.11.1217
Low dose oral methotrexate treatment of multiple sclerosis: a pilot study
Erratum in
- J Neurol Neurosurg Psychiatry 1994 Apr;57(4):528
Abstract
An 18-month double-blind treatment of multiple sclerosis with low dose oral methotrexate showed it to be well tolerated and suggested effectiveness in exacerbating-remitting MS but not in the exacerbating progressive and chronic progressive stages.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical